Influence of APOE and RNF219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or Alzheimer's disease

Alessandra Mosca, Samantha Sperduti, Viorela Pop, Domenico Ciavardelli, Alberto Granzotto, Miriam Punzi, Liborio Stuppia, Valentina Gatta, Francesca Assogna, Nerisa Banaj, Federica Piras, Federica Piras, Carlo Caltagirone, Gianfranco Spalletta, Stefano L. Sensi

Research output: Contribution to journalArticle

Abstract

The risk for Alzheimer's disease (AD) is associated with the presence of the ε4 allele of Apolipoprotein E (APOE) gene and, recently, with a novel genetic variant of the RNF219 gene. This study aimed at evaluating interactions between APOE-ε4 and RNF219/G variants in the modulation of behavioral and cognitive features of two cohorts of patients suffering from mild cognitive impairment (MCI) or AD. We enrolled a total of 173 female MCI or AD patients (83 MCI; 90 AD). Subjects were screened with a comprehensive set of neuropsychological evaluations and genotyped for the APOE and RNF219 polymorphic variants. Analysis of covariance was performed to assess the main and interaction effects of APOE and RNF219 genotypes on the cognitive and behavioral scores. The analysis revealed that the simultaneous presence of APOE-ε4 and RNF219/G variants results in significant effects on specific neuropsychiatric scores in MCI and AD patients. In MCI patients, RNF219 and APOE variants worked together to impact the levels of anxiety negatively. Similarly, in AD patients, the RNF219 variants were found to be associated with increased anxiety levels. Our data indicate a novel synergistic activity APOE and RNF219 in the modulation of behavioral traits of female MCI and AD patients.

Original languageEnglish
Article number92
JournalFrontiers in Aging Neuroscience
Volume10
Issue numberAPR
DOIs
Publication statusPublished - Apr 13 2018

Fingerprint

Apolipoproteins E
Alzheimer Disease
Apolipoprotein E4
Anxiety
Cognitive Dysfunction
Genes
Alleles
Genotype

Keywords

  • Alzheimer disease (AD)
  • APOE
  • Dementia
  • Genotype
  • Mild cognitive impairment (MCI)
  • RNF219

ASJC Scopus subject areas

  • Ageing
  • Cognitive Neuroscience

Cite this

Influence of APOE and RNF219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or Alzheimer's disease. / Mosca, Alessandra; Sperduti, Samantha; Pop, Viorela; Ciavardelli, Domenico; Granzotto, Alberto; Punzi, Miriam; Stuppia, Liborio; Gatta, Valentina; Assogna, Francesca; Banaj, Nerisa; Piras, Federica; Piras, Federica; Caltagirone, Carlo; Spalletta, Gianfranco; Sensi, Stefano L.

In: Frontiers in Aging Neuroscience, Vol. 10, No. APR, 92, 13.04.2018.

Research output: Contribution to journalArticle

Mosca, Alessandra ; Sperduti, Samantha ; Pop, Viorela ; Ciavardelli, Domenico ; Granzotto, Alberto ; Punzi, Miriam ; Stuppia, Liborio ; Gatta, Valentina ; Assogna, Francesca ; Banaj, Nerisa ; Piras, Federica ; Piras, Federica ; Caltagirone, Carlo ; Spalletta, Gianfranco ; Sensi, Stefano L. / Influence of APOE and RNF219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or Alzheimer's disease. In: Frontiers in Aging Neuroscience. 2018 ; Vol. 10, No. APR.
@article{1a886d2190b24e04bf5f0a42082aa6bb,
title = "Influence of APOE and RNF219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or Alzheimer's disease",
abstract = "The risk for Alzheimer's disease (AD) is associated with the presence of the ε4 allele of Apolipoprotein E (APOE) gene and, recently, with a novel genetic variant of the RNF219 gene. This study aimed at evaluating interactions between APOE-ε4 and RNF219/G variants in the modulation of behavioral and cognitive features of two cohorts of patients suffering from mild cognitive impairment (MCI) or AD. We enrolled a total of 173 female MCI or AD patients (83 MCI; 90 AD). Subjects were screened with a comprehensive set of neuropsychological evaluations and genotyped for the APOE and RNF219 polymorphic variants. Analysis of covariance was performed to assess the main and interaction effects of APOE and RNF219 genotypes on the cognitive and behavioral scores. The analysis revealed that the simultaneous presence of APOE-ε4 and RNF219/G variants results in significant effects on specific neuropsychiatric scores in MCI and AD patients. In MCI patients, RNF219 and APOE variants worked together to impact the levels of anxiety negatively. Similarly, in AD patients, the RNF219 variants were found to be associated with increased anxiety levels. Our data indicate a novel synergistic activity APOE and RNF219 in the modulation of behavioral traits of female MCI and AD patients.",
keywords = "Alzheimer disease (AD), APOE, Dementia, Genotype, Mild cognitive impairment (MCI), RNF219",
author = "Alessandra Mosca and Samantha Sperduti and Viorela Pop and Domenico Ciavardelli and Alberto Granzotto and Miriam Punzi and Liborio Stuppia and Valentina Gatta and Francesca Assogna and Nerisa Banaj and Federica Piras and Federica Piras and Carlo Caltagirone and Gianfranco Spalletta and Sensi, {Stefano L.}",
year = "2018",
month = "4",
day = "13",
doi = "10.3389/fnagi.2018.00092",
language = "English",
volume = "10",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Research Foundation",
number = "APR",

}

TY - JOUR

T1 - Influence of APOE and RNF219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or Alzheimer's disease

AU - Mosca, Alessandra

AU - Sperduti, Samantha

AU - Pop, Viorela

AU - Ciavardelli, Domenico

AU - Granzotto, Alberto

AU - Punzi, Miriam

AU - Stuppia, Liborio

AU - Gatta, Valentina

AU - Assogna, Francesca

AU - Banaj, Nerisa

AU - Piras, Federica

AU - Piras, Federica

AU - Caltagirone, Carlo

AU - Spalletta, Gianfranco

AU - Sensi, Stefano L.

PY - 2018/4/13

Y1 - 2018/4/13

N2 - The risk for Alzheimer's disease (AD) is associated with the presence of the ε4 allele of Apolipoprotein E (APOE) gene and, recently, with a novel genetic variant of the RNF219 gene. This study aimed at evaluating interactions between APOE-ε4 and RNF219/G variants in the modulation of behavioral and cognitive features of two cohorts of patients suffering from mild cognitive impairment (MCI) or AD. We enrolled a total of 173 female MCI or AD patients (83 MCI; 90 AD). Subjects were screened with a comprehensive set of neuropsychological evaluations and genotyped for the APOE and RNF219 polymorphic variants. Analysis of covariance was performed to assess the main and interaction effects of APOE and RNF219 genotypes on the cognitive and behavioral scores. The analysis revealed that the simultaneous presence of APOE-ε4 and RNF219/G variants results in significant effects on specific neuropsychiatric scores in MCI and AD patients. In MCI patients, RNF219 and APOE variants worked together to impact the levels of anxiety negatively. Similarly, in AD patients, the RNF219 variants were found to be associated with increased anxiety levels. Our data indicate a novel synergistic activity APOE and RNF219 in the modulation of behavioral traits of female MCI and AD patients.

AB - The risk for Alzheimer's disease (AD) is associated with the presence of the ε4 allele of Apolipoprotein E (APOE) gene and, recently, with a novel genetic variant of the RNF219 gene. This study aimed at evaluating interactions between APOE-ε4 and RNF219/G variants in the modulation of behavioral and cognitive features of two cohorts of patients suffering from mild cognitive impairment (MCI) or AD. We enrolled a total of 173 female MCI or AD patients (83 MCI; 90 AD). Subjects were screened with a comprehensive set of neuropsychological evaluations and genotyped for the APOE and RNF219 polymorphic variants. Analysis of covariance was performed to assess the main and interaction effects of APOE and RNF219 genotypes on the cognitive and behavioral scores. The analysis revealed that the simultaneous presence of APOE-ε4 and RNF219/G variants results in significant effects on specific neuropsychiatric scores in MCI and AD patients. In MCI patients, RNF219 and APOE variants worked together to impact the levels of anxiety negatively. Similarly, in AD patients, the RNF219 variants were found to be associated with increased anxiety levels. Our data indicate a novel synergistic activity APOE and RNF219 in the modulation of behavioral traits of female MCI and AD patients.

KW - Alzheimer disease (AD)

KW - APOE

KW - Dementia

KW - Genotype

KW - Mild cognitive impairment (MCI)

KW - RNF219

UR - http://www.scopus.com/inward/record.url?scp=85045771867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045771867&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2018.00092

DO - 10.3389/fnagi.2018.00092

M3 - Article

AN - SCOPUS:85045771867

VL - 10

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - APR

M1 - 92

ER -